Work

Abstract 1937: YAP-TAZ-TEAD transcriptional program is a prominent driver of acquired resistance to KRASG12C-based therapies in patients with metastatic colorectal cancer

Year: 2024

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2024-1937

Authors: Oluwadara Coker, Alexey Sorokin, Neal Akhave, Kelsey Pan, Fengqin Gao, Zhensheng Liu, Preeti Kanikarla, HeyMin Lee, Oscar Villarreal, Jumanah Alshenaifi, Giulia Maddalena, Alaa Mohamed, Dionne Prescod, David Menter, Saikat Chowdury, Ryan Corcoran, Kunal Rai, David Hong, Scott Kopetz

Institutions: The University of Texas MD Anderson Cancer Center, Harvard University

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4393073494

Cites:

Cited by:

Related to: 10